Insider · CIK 0001181152

BONDURANT STUART

Reports to the SEC for 2 companies · CHAPEL HILL, NC

sec.gov

Transactions

Companies

Filings

CIK

0001181152

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2011-12-05	Furiex Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+2,800 sh	$17.87	+$50K	6,697
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCD Disposition to Issuer	Director	DDisposition to Issuer	−21.5K sh	$33.25	−$714K	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,095 sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,485 sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,341 sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,113 sh	—	—	0
2011-12-05	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,650 sh	—	—	0
2011-10-12	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+8,825 sh	—	—	8,825
2011-10-12	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+8,825 sh	—	—	8,825
2011-05-19	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+8,675 sh	—	—	8,675
2011-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director	AAward	+9,095 sh	—	—	9,095
2011-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+1,139 sh	—	—	21,479
2011-05-11	Furiex Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+3,300 sh	$15.25	+$50.3K	3,896
2011-01-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+2,355 sh	—	—	20,199
2010-06-17	Furiex Pharmaceuticals, Inc.Stock Options (to buy)A Award	Director	AAward	+17.6K sh	—	—	17,570
2010-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director	AAward	+10.1K sh	—	—	10,140
2010-01-04	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+2,799 sh	—	—	17,844
2009-05-20	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director	AAward	+13.6K sh	—	—	13,577
2009-01-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+2,242 sh	—	—	15,045
2008-01-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+1,588 sh	—	—	12,803
2006-01-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+1,032 sh	—	—	4,612
2005-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director	AAward	+2,729 sh	—	—	2,729
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$31.64	+$127K	7,580
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director	SSale	−26K sh	$45.64	−$1.19M	3,580
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	22,000
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,000 sh	—	—	16,000
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	—	—	8,000
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,000 sh	—	—	0
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$27.16	+$217K	21,580
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director	MExercise/Conversion	+6,000 sh	$25.61	+$154K	13,580
2005-04-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$30.11	+$241K	29,580
2005-01-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director	AAward	+1,580 sh	—	—	3,580

Recent filings

Accepted (ET)
Dec 74/A
BONDURANT STUART0001181431-11-059295
SEC(opens sec.gov)
Dec 74
BONDURANT STUART0001181431-11-059298
SEC(opens sec.gov)
Dec 64
BONDURANT STUART0001181152-11-000003
SEC(opens sec.gov)
Oct 144
BONDURANT STUART0001181431-11-052785
SEC(opens sec.gov)
May 234
BONDURANT STUART0001181431-11-032046
SEC(opens sec.gov)
May 194
BONDURANT STUART0001181152-11-000002
SEC(opens sec.gov)
May 124
BONDURANT STUART0001181431-11-029016
SEC(opens sec.gov)
Jan 44
BONDURANT STUART0001181152-11-000001
SEC(opens sec.gov)
Jun 214
BONDURANT STUART0001181431-10-034109
SEC(opens sec.gov)
May 214
BONDURANT STUART0001181152-10-000002
SEC(opens sec.gov)
Jan 54
BONDURANT STUART0001181152-10-000001
SEC(opens sec.gov)
May 224
BONDURANT STUART0001181152-09-000002
SEC(opens sec.gov)

Companies

Address

205 UNIVERSITY DRIVE

CHAPEL HILL, NC, 27514